Zhejiang Hisun Pharmaceutical Co (SHSE:600267) Cyclically Adjusted Book per Share: ¥7.14 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600267 Zhejiang Hisun Pharmaceutical Co Ltd SHSE:600267
58 GF Score
Price ¥11.72
GF Value ¥8.85
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Zhejiang Hisun Pharmaceutical Co Cyclically Adjusted Book per Share?

Zhejiang Hisun Pharmaceutical Co SHSE:600267 -1.18% 58 Cyclically Adjusted Book per Share is ¥7.14 as of Mar. 2026. GuruFocus rates SHSE:600267 with a GF Score™ of 58/100 and a GF Value™ of ¥8.85 (Significantly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Zhejiang Hisun Pharmaceutical Co's adjusted book value per share for the three months ended in Mar. 2026 was ¥7.464. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥7.14 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Zhejiang Hisun Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was -0.40% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -0.70% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 0.10% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 4.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Zhejiang Hisun Pharmaceutical Co was 22.40% per year. The lowest was -0.70% per year. And the median was 10.40% per year.

As of today (2026-07-28), Zhejiang Hisun Pharmaceutical Co's current stock price is ¥11.72. Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ¥7.14. Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 1.64.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Zhejiang Hisun Pharmaceutical Co was 3.05. The lowest was 0.95. And the median was 1.72.


Zhejiang Hisun Pharmaceutical Co  (SHSE:600267) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=11.72/7.14
=1.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Zhejiang Hisun Pharmaceutical Co was 3.05. The lowest was 0.95. And the median was 1.72.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Zhejiang Hisun Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


Zhejiang Hisun Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Hisun Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Zhejiang Hisun Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.17 7.27 7.27 7.19 7.12

Zhejiang Hisun Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.17 7.12 7.13 7.12 7.14

SHSE:600267 vs ZTS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Hisun Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


SHSE:600267
58GF Score
Zhejiang Hisun Pharmaceutical Co Ltd SHSE:600267
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Hisun Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zhejiang Hisun Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=7.464/116.3033*116.3033
=7.464

Current CPI (Mar. 2026) = 116.3033.

Zhejiang Hisun Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 7.116 101.400 8.162
201609 7.126 102.400 8.094
201612 6.996 102.600 7.930
201703 7.003 103.200 7.892
201706 6.961 103.100 7.852
201709 6.954 104.100 7.769
201712 6.962 104.500 7.748
201803 6.976 105.300 7.705
201806 6.927 104.900 7.680
201809 6.917 106.600 7.547
201812 6.404 106.500 6.993
201903 6.438 107.700 6.952
201906 6.458 107.700 6.974
201909 7.704 109.800 8.160
201912 6.498 111.200 6.796
202003 6.419 112.300 6.648
202006 6.847 110.400 7.213
202009 6.888 111.700 7.172
202012 6.917 111.500 7.215
202103 5.987 112.662 6.181
202106 6.103 111.769 6.351
202109 6.148 112.215 6.372
202112 6.106 113.108 6.279
202203 6.217 114.335 6.324
202206 6.231 114.558 6.326
202209 6.459 115.339 6.513
202212 6.743 115.116 6.813
202303 7.014 115.116 7.086
202306 7.122 114.558 7.231
202309 7.096 115.339 7.155
202312 6.708 114.781 6.797
202403 6.660 115.227 6.722
202406 6.720 114.781 6.809
202409 6.833 115.785 6.864
202412 6.958 114.893 7.043
202503 7.120 115.116 7.193
202506 6.962 114.907 7.047
202509 7.099 115.471 7.150
202512 7.180 115.832 7.209
202603 7.464 116.303 7.464

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥7.14 mean?
Zhejiang Hisun Pharmaceutical Co (SHSE:600267) has a Cyclically Adjusted Book per Share of ¥7.14 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Zhejiang Hisun Pharmaceutical Co and its competitors.
Is Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
Zhejiang Hisun Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥7.14. Overall, Zhejiang Hisun Pharmaceutical Co has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted Book per Share compare to ZTS?
Zhejiang Hisun Pharmaceutical Co's Cyclically Adjusted Book per Share of ¥7.14 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Zhejiang Hisun Pharmaceutical Co and its competitors. Zhejiang Hisun Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥7.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Hisun Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Hisun Pharmaceutical Co (SHSE:600267) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥8.85, compared to a current price of ¥11.72 — trading 32.4% above its estimated fair value. The current Cyclically Adjusted Book per Share is ¥7.14. Zhejiang Hisun Pharmaceutical Co's overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Zhejiang Hisun Pharmaceutical Co (SHSE:600267), the current Cyclically Adjusted Book per Share is ¥7.14 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhejiang Hisun Pharmaceutical Co (SHSE:600267) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Hisun Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥11.72 is trading 32.4% above its estimated GF Value™ of ¥8.85. GuruFocus considers Zhejiang Hisun Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for SHSE:600267:

  • Cyclically Adjusted Book per Share: ¥7.14
  • GF Value™: ¥8.85 vs. price of ¥11.72 (32.4% above fair value)
  • GF Score™: 58/100 with 4 warning signs

No single metric tells the full story. See the SHSE:600267 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zhejiang Hisun Pharmaceutical Co Business Description

Address No. 46 Waisha Road, Jiaojiang District, Zhejiang Province, Taizhou, CHN, 318000
Zhejiang Hisun Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is focused on the research, development, and distribution of pharmaceuticals. It produces and supplies antibiotics and anticancer drugs. The company's research channels cover indications like anticancer, cardiovascular, anti-infective, anti-parasitic, immunosuppressant and others. Its product portfolio includes active pharmaceutical ingredients like Anastrozole, Docetaxel, Methotrexate, and others and finished dosages such as letrozole tablets, anastrozole tablets, injection mitomycin, and others.
58GF Score

Get the complete analysis for SHSE:600267

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥11.72
Price
¥8.85
GF Value